UC San Diego, HRPP Home page
-
July 3, 2021
Preparation for the July 7 launch of Kuali IRB
-
In preparation for the July 7 launch of Kuali IRB, two buttons now appear in the top right of our website, one for the legacy e-IRB Services and one for Kuali IRB. Please see this matrix for guidance about which system to use during the yearlong rolling transition. We have also de-activated links to the various forms for new submissions throughout our website; please do not use any copies of these forms that you might have retained locally. e-IRB Services remains active for responses, amendments, reports, continuing reviews and closures related to existing studies. Submissions for new studies will only be accepted in Kuali IRB. Please see the May 22 news item below for links to additional information about the Kuali IRB project.
-
June 14, 2021
Contacting the Office of IRB Administration
-
As part of our customer support for the upcoming launch of Kuali IRB, we have gone live with the ServiceNow ticketing system already used by units across UC San Diego.
When you send an e-mail to our general or reliance addresses or when you leave a voicemail at our general contact number, a ticket will be automatically generated. For e-mails, you will receive a confirmation of the ticket. This confirmation does not require any action on your part.
ServiceNow does not change how you can get in touch with us, it simply helps us better route and track your questions. Our goal is not just to promptly take care of your question, but to make sure we are actively identifying patterns and getting information or solutions out to everyone who might have similar questions.
You also now have the option of opening a ticket at https://support.ucsd.edu/research without sending an email or calling us. That page will become the home for IRB-related Knowledge Base articles as we update our guidance and frequently asked questions.
-
May 22, 2021
Changes Are Underway — Stay Informed!
-
We are preparing to go live with the Kuali IRB system (July 7, 2021) and to roll out other exciting changes to our program over the coming months, including a new identity as the Office of IRB Administration (OIA)!
Instead of remembering to check this space and the Kuali IRB project pages, sign up now at the links below to have the updates you want delivered to your inbox:
We appreciate that you are inundated with emails. Although we will make a number of announcements on each list over the next 3 to 4 months, be assured that by the end of the year we will have deactivated the Kuali IRB list and settled into a calmer pace with the Human Research News list.
Finally, if you haven't kept up with the Kuali IRB rollout don't panic! July 7 will mark the start of a yearlong transition period. Now is the time to catch up if you:
- Expect to submit new projects for review this summer
- Will need to renew existing projects that expire in September or October
To refresh yourself (or to get caught up), take a quick look at both the Kuali IRB Project Page and the Kuali IRB Updates distributed so far. This matrix breaks down when to use Kuali IRB and when to use the legacy e-IRB Services during the transition period.
If you won't be submitting new projects or renewals until this fall (or beyond), you can learn more now or check in with us later. Information and training will continue to be available after go-live.
-
May 22, 2020
COVID-19-Related Clinical Trials
-
For study teams preparing COVID-19-related clinical trials, please note that UC San Diego Health has established the COVID-19 Clinical Trials Review Committee (CCTRC). Clinical trials falling under the purview of the CCTRC must be approved by that committee before submission for IRB review.
Any new submission to the HRPP of an applicable clinical trial must include documentation of CCTRC review in order to continue through the IRB review process. This includes trials that will be reviewed by an external IRB (such as a commercial IRB or the IRB of a collaborating site).
The HRPP and the IRBs appreciate the urgency of COVID-19-related clinical trials and we are working with the CCTRC to coordinate our processes. This new step will improve study initiation by allowing the IRB to focus on its core responsibilities. This ultimately best serves our shared responsibility to protect UCSD patients and research subjects.
For more information about the CCTRC, its application form, and administrative contacts for questions, please visit the COVID-19 page on Pulse (AD login required), go to “Clinical Care Resources” and then expand the “Clinical Trials” section.
-
April 29, 2020
Clarification of IRB Approval Periods
-
A clarfication memo is available addressing questions and concerns about how the IRB database calculates and displays expiration dates and how approval and expiration are explained in IRB procedures and approval letters, all further complicated by the 2019 leap year. Despite the confusion, the UCSD IRB does conduct continuing reviews at intervals required by regulation.
This memo can be provided to sponsors or attached as a Note to File. We apologize for the inconvenience and confusion.
-
April 14, 2020
New Forms for Secondary Research
-
New forms have been created for studies that only propose the secondary use of data, records, or biospecimens. Secondary Use means the data/records/biospecimens to be used are/were initially collected for a purpose other than the proposed research. These forms are to be used regardless of the expected level of review. They replace both the Exempt Category 4 and Existing Medical Record Review forms. The new forms can be found here .
-
April 14, 2020
No Longer Acknowledging Key Personnel Changes
-
The HRPP/IRB will no longer acknowledge the submission of a completed “Cover Letter for Request Change/Modification to an Approved Study – Key Personnel Changes Only” form. Submitting the form or a copy of the signed delegation log with additions/removals highlighted will be considered sufficient to inform the IRB/HRPP of key personnel changes associated with the study. The HRPP database will be updated as soon as possible following the submission of the form/log. More information can be found here.
-
March 13, 2020
(Updated March 18, 2020)
Coronavirus (COVID-19) Guidance
-
The latest guidance information, updated March 18, 2020, regarding Coronavirus (COVID-19), the UCSD IRB, and human research studies can be found at https://irb.ucsd.edu/IRB-COVID-19-Guidance.pdf . Additional updates, as needed, will be posted on this website.
-
January 6, 2020
Federally Supported Multisite Projects - sIRB
-
Principal Investigators that have started new federally supported multisite projects since January 21, 2019 or are planning new proposals for such projects should especially be aware of the new requirement regarding single IRB (sIRB) review. More information about this requirement can be found here . For additional assistance, please contact the HRPP Office at irbrely@ucsd.edu .
-
June 21, 2019
Updated FWA Statement Letter
-
HRPP is making available an updated FWA statement letter. In addition to updating information, the letter now covers both UCSD and RCHSD and also addresses several common sponsor requests. This new content is intended to help UCSD and RCHSD PIs and Study Teams negotiate with sponsors about the standard HIPAA authorization for research or the standard consent language about treatment and compensation for injuries. To access the new letter, please see the About HRPP web page or click here .
-
January 19, 2019
Revised Common Rule
-
On January 21, 2019, a number of changes to the Federal Policy for the Protection of Human Subjects (aka the Common Rule) are scheduled to take effect. At this time, the UCSD IRBs and HRPP will only apply these changes to federally supported research that will receive initial IRB approval or initial certification of exemptions on or after January 21, 2019. Additional information for these changes can be found here and specifically for changes associated with the consent process, see here.
-
HIPAA (Health Insurance Portability and Accountability Act of 1996) information for researchers
-
Older News Items